GlassScriptPhysician profile
Sovana R Moore
NPI 1679530745
$1,663.53
in general payments reported to CMS, 2019-2025
18 companies · $459 in 2025
The $459 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $11.92 · 2021: $92.14 · 2022: $158 · 2023: $394 · 2024: $443 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,206 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,205.72 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $322.78 | 2019-2025 | Aptima |
| Astellas Pharma US INC | $229.88 | 2023-2025 | Veozah |
| Abbvie INC. | $199.52 | 2019-2025 | |
| Exeltis, USA INC. | $193.91 | 2022-2025 | Slynd |
| Coopersurgical, INC. | $181.61 | 2023-2025 | Endosee, Summit Doppler, Paragard T 380a |
| Organon LLC | $123.64 | 2021-2025 | Jada System, Nexplanon |
| Sage Therapeutics, LLC | $72.78 | 2025 | Zurzuvae |
| Novo Nordisk INC | $60.96 | 2023-2024 | Wegovy, Saxenda |
| Merck Sharp & Dohme LLC | $47.88 | 2020-2023 | Gardasil 9 |
| Smith+Nephew, INC. | $47.46 | 2019-2025 | Pico 14 |
| Mayne Pharma Commercial LLC | $42.60 | 2023 | |
| Millicent US INC | $31.29 | 2025 | Intrarosa, Femring, Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $28.58 | 2025 | |
| Ascend Therapeutics US, LLC | $24.46 | 2019 | |
| Agile Therapeutics, INC. | $20.03 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13.15 | 2019 | |
| Covidien LP | $11.90 | 2019 | |
| Allergan, INC. | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sovana Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.